$MFIN
MEDALLION FINANCIAL CORP

2022 Q1 Form 10-Q Financial Statement

#000095017022007799 Filed on May 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $43.30M $37.08M
YoY Change 16.78% 4.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.640M $1.321M
YoY Change 24.15% -16.92%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $7.375M $8.407M
YoY Change -12.28% -6.59%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $16.18M $12.95M
YoY Change 24.98% -179.69%
Income Tax $4.831M $3.878M
% Of Pretax Income 29.85% 29.95%
Net Earnings $9.841M $8.431M
YoY Change 16.72% -161.8%
Net Earnings / Revenue 22.73% 22.74%
Basic Earnings Per Share $0.40 $0.34
Diluted Earnings Per Share $0.54 $0.34
COMMON SHARES
Basic Shares Outstanding 24.77M 24.52M
Diluted Shares Outstanding 25.08M 24.90M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $104.0M
YoY Change
Cash & Equivalents $56.95M $140.3M
Short-Term Investments $47.08M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $11.61M $11.90M
YoY Change -2.48% -14.39%
Goodwill $150.8M $150.8M
YoY Change 0.0% 0.0%
Intangibles $23.12M $50.73M
YoY Change -54.42% -2.77%
Long-Term Investments $10.08M $9.500M
YoY Change 6.06% -7.77%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.967B $1.689B
YoY Change 16.45% 10.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.068M $4.800M
YoY Change -36.08% 45.45%
Accrued Expenses $10.70M $12.50M
YoY Change -14.39% -12.59%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $73.90M
YoY Change 21.35%
Total Short-Term Liabilities $27.67M $91.20M
YoY Change -69.66% -2.15%
LONG-TERM LIABILITIES
Long-Term Debt $220.0M $182.2M
YoY Change 20.75% 20.74%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $220.0M $182.2M
YoY Change 20.75% 20.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.67M $91.20M
Total Long-Term Liabilities $220.0M $182.2M
Total Liabilities $1.605B $1.449B
YoY Change 10.74% 12.82%
SHAREHOLDERS EQUITY
Retained Earnings $38.40M
YoY Change
Common Stock $281.1M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $25.54M
YoY Change
Treasury Stock Shares $3.019M
Shareholders Equity $293.3M $239.7M
YoY Change
Total Liabilities & Shareholders Equity $1.967B $1.689B
YoY Change 16.45% 10.06%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $9.841M $8.431M
YoY Change 16.72% -161.8%
Depreciation, Depletion And Amortization $1.640M $1.321M
YoY Change 24.15% -16.92%
Cash From Operating Activities $24.65M $21.06M
YoY Change 17.07% 25.43%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$87.69M -$27.55M
YoY Change 218.28% -20.42%
Cash From Investing Activities -$87.69M -$27.55M
YoY Change 218.31% -20.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $617.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 77.34M 34.72M
YoY Change 122.73% 530.31%
NET CHANGE
Cash From Operating Activities 24.65M 21.06M
Cash From Investing Activities -87.69M -27.55M
Cash From Financing Activities 77.34M 34.72M
Net Change In Cash 14.31M 28.24M
YoY Change -49.32% -329.12%
FREE CASH FLOW
Cash From Operating Activities $24.65M $21.06M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.medallion.com/20220331#PropertyEquipmentAndRightOfUseAssetNet
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2026-02-28
CY2022Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityNoncurrent
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.medallion.com/20220331#PropertyEquipmentAndRightOfUseAssetNet
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityNoncurrent
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001000209
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-37747
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
MEDALLION FINANCIAL CORP
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3291176
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
437 MADISON AVENUE, 38th Floor
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
NEW YORK
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
CY2022Q1 dei City Area Code
CityAreaCode
212
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
328-2100
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
MFIN
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25506630
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56951000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64482000
CY2022Q1 us-gaap Federal Funds Sold
FederalFundsSold
81843000
CY2021Q4 us-gaap Federal Funds Sold
FederalFundsSold
60002000
CY2022Q1 us-gaap Marketable Securities
MarketableSecurities
47075000
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
44772000
CY2022Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1569441000
CY2021Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1488924000
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
10076000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
9726000
CY2022Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
50686000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
50166000
CY2022Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1518755000
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1438758000
CY2022Q1 us-gaap Goodwill
Goodwill
150803000
CY2021Q4 us-gaap Goodwill
Goodwill
150803000
CY2022Q1 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
33834000
CY2021Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
37430000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23120000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23480000
CY2022Q1 mfin Property Equipment And Right Of Use Asset Net
PropertyEquipmentAndRightOfUseAssetNet
11605000
CY2021Q4 mfin Property Equipment And Right Of Use Asset Net
PropertyEquipmentAndRightOfUseAssetNet
11762000
CY2022Q1 us-gaap Interest Receivable
InterestReceivable
10603000
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
10621000
CY2022Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
184000
CY2021Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
833000
CY2022Q1 us-gaap Other Assets
OtherAssets
21776000
CY2021Q4 us-gaap Other Assets
OtherAssets
20388000
CY2022Q1 us-gaap Assets
Assets
1966625000
CY2021Q4 us-gaap Assets
Assets
1873057000
CY2022Q1 us-gaap Deposits
Deposits
1332112000
CY2021Q4 us-gaap Deposits
Deposits
1250880000
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
220006000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
219973000
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
21731000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
18210000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8548000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9053000
CY2022Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3068000
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3395000
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
19119000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
15718000
CY2022Q1 us-gaap Liabilities
Liabilities
1604584000
CY2021Q4 us-gaap Liabilities
Liabilities
1517229000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28526016
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28124629
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
285000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
281000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
280784000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
280038000
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
3018903
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2951243
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
25536000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
24919000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-683000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1034000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
38403000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
30606000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
293253000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
287040000
CY2022Q1 us-gaap Minority Interest
MinorityInterest
68788000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
68788000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
362041000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
355828000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1966625000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1873057000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25507113
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25173386
CY2022Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
11.50
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
11.40
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
0
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
3000000.0
CY2022Q1 mfin Loan Foreclosure Collateral Sale To Third Party
LoanForeclosureCollateralSaleToThirdParty
7700000
CY2021Q4 mfin Loan Foreclosure Collateral Sale To Third Party
LoanForeclosureCollateralSaleToThirdParty
7400000
CY2021Q4 mfin Short Term Lease Liabilities
ShortTermLeaseLiabilities
2200000
CY2022Q1 mfin Short Term Lease Liabilities
ShortTermLeaseLiabilities
2200000
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
43064000
CY2021Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
36855000
CY2022Q1 mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
239000
CY2021Q1 mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
225000
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
43303000
CY2021Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
37080000
CY2022Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
4154000
CY2021Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
4711000
CY2022Q1 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
3221000
CY2021Q1 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
3293000
CY2022Q1 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
0
CY2021Q1 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
403000
CY2022Q1 us-gaap Interest Expense
InterestExpense
7375000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
35928000
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
28673000
CY2021Q1 us-gaap Interest Expense
InterestExpense
8407000
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3240000
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3019000
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
32688000
CY2021Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
25654000
CY2022Q1 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-133000
CY2021Q1 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0
CY2022Q1 mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
386000
CY2021Q1 mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
2785000
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1767000
CY2022Q1 mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
0
CY2021Q1 mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
2473000
CY2022Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
2048000
CY2021Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
482000
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
1529000
CY2021Q1 us-gaap Noninterest Income
NoninterestIncome
1937000
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7568000
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5685000
CY2022Q1 mfin Loan Servicing Fee
LoanServicingFee
1953000
CY2021Q1 mfin Loan Servicing Fee
LoanServicingFee
1647000
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
3992000
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
507000
CY2022Q1 mfin Collection Costs
CollectionCosts
1343000
CY2021Q1 mfin Collection Costs
CollectionCosts
1232000
CY2022Q1 mfin Lease And Rental Expense1
LeaseAndRentalExpense1
645000
CY2021Q1 mfin Lease And Rental Expense1
LeaseAndRentalExpense1
675000
CY2022Q1 mfin Regulatory Fees
RegulatoryFees
451000
CY2021Q1 mfin Regulatory Fees
RegulatoryFees
438000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
360000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
361000
CY2022Q1 mfin Race Team Related Expense
RaceTeamRelatedExpense
0
CY2021Q1 mfin Race Team Related Expense
RaceTeamRelatedExpense
-2122000
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1721000
CY2021Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1975000
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
18033000
CY2021Q1 us-gaap Noninterest Expense
NoninterestExpense
14642000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16184000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12949000
CY2022Q1 mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
4831000
CY2021Q1 mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
3878000
CY2022Q1 mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
11353000
CY2021Q1 mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
9071000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1512000
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
640000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
9841000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
8431000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24770134
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24518775
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25083566
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24895108
CY2022Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
200000
CY2021Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
300000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
11353000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
9071000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1717000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-605000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
9636000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
8466000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1512000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
640000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8124000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7826000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
355828000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
11353000
CY2022Q1 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1512000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
598000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
152000
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
617000
CY2022Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.08
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
2044000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1717000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
362041000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
304561000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
9071000
CY2021Q1 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1511000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
498000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-605000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
312014000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
11353000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
9071000
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
3240000
CY2021Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
3019000
CY2022Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
172000
CY2021Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
325000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1640000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1321000
CY2022Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-2119000
CY2021Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-1656000
CY2022Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
4170000
CY2021Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
3620000
CY2022Q1 mfin Net Change In Loan Collateral In Process Of Foreclosure
NetChangeInLoanCollateralInProcessOfForeclosure
-1396000
CY2021Q1 mfin Net Change In Loan Collateral In Process Of Foreclosure
NetChangeInLoanCollateralInProcessOfForeclosure
-4002000
CY2022Q1 mfin Gain Loss On Sale Of Loans And Investments
GainLossOnSaleOfLoansAndInvestments
-241000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
598000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
498000
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1767000
CY2022Q1 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-18000
CY2021Q1 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-1123000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2455000
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2228000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2833000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
944000
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-327000
CY2021Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
126000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24654000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21060000
CY2022Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
217495000
CY2021Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
150598000
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
129121000
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
113144000
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
8407000
CY2021Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2000000
CY2022Q1 us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
3856000
CY2021Q1 us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
8280000
CY2022Q1 mfin Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure
ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure
5240000
CY2021Q1 mfin Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure
ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure
3627000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-87685000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27547000
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
200528000
CY2021Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
181179000
CY2022Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
119226000
CY2021Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
144944000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1984000
CY2022Q1 mfin Distributions To Noncontrolling Interests
DistributionsToNoncontrollingInterests
1512000
CY2021Q1 mfin Distributions To Noncontrolling Interests
DistributionsToNoncontrollingInterests
1511000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
617000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
152000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
77341000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34724000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14310000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
28237000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
124484000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
112040000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
138794000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
140277000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
7056000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
7637000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000
CY2022Q1 mfin Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure
NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure
3040000
CY2021Q1 mfin Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure
NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure
3802000
CY2022Q1 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
8700000
CY2022Q1 mfin Number Of Medallions
NumberOfMedallions
159
CY2022Q1 us-gaap Reorganization Value Net Realizable Value Of Asset Dispositions
ReorganizationValueNetRealizableValueOfAssetDispositions
1000000.0
CY2021Q4 us-gaap Reorganization Value Net Realizable Value Of Asset Dispositions
ReorganizationValueNetRealizableValueOfAssetDispositions
1000000.0
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the US, or GAAP, requires management to make estimates that affect the amounts reported in the consolidated financial statements and the accompanying notes. Accounting estimates and assumptions are those that management considers to be the most critical to an understanding of the consolidated financial statements because they inherently involve significant judgments and uncertainties. All of these estimates reflect management’s best judgment about current economic and market conditions and their effects based on information available as of the date of these consolidated financial statements. If such conditions change, it is reasonably possible that the judgments and estimates could change, which may result in future impairments of loans and loan collateral in process of foreclosure, goodwill and intangible assets, and investments, among other effects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2022Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
1300000
CY2022Q1 mfin Non Marketable Securities
NonMarketableSecurities
10100000
CY2021Q4 mfin Non Marketable Securities
NonMarketableSecurities
9700000
CY2022Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-91000
CY2021Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-28000
CY2022Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0
CY2021Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-91000
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-28000
CY2022Q1 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
100000
CY2021Q1 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
100000
CY2022Q1 mfin Deferred Loan Origination Costs
DeferredLoanOriginationCosts
28400000
CY2021 mfin Deferred Loan Origination Costs
DeferredLoanOriginationCosts
26100000
CY2022Q1 mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
2100000
CY2021Q1 mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
1700000
CY2022Q1 mfin Financing Receivables Impaired Troubled Debt Restructuring Write Down As Percentage Of Loans
FinancingReceivablesImpairedTroubledDebtRestructuringWriteDownAsPercentageOfLoans
0.40
CY2022Q1 us-gaap Notes Receivable Net
NotesReceivableNet
79500
CY2022Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
20500000
CY2021Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
20500000
CY2022Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2022Q1 us-gaap Goodwill
Goodwill
150800000
CY2021Q4 us-gaap Goodwill
Goodwill
150800000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23100000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23500000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23120000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23480000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000
CY2022Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
600000
CY2021Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
600000
CY2022Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
7200000
CY2021Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
7100000
CY2022Q1 mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
9841000
CY2021Q1 mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
8431000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24770134
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24518775
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
89507
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
21168
CY2022Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
223925
CY2021Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
355165
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25083566
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24895108
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
466867
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1188455
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
317398
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
600000
CY2022Q1 us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.02
CY2021Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
500000
CY2021Q1 us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.02
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5100000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P12M
CY2022Q1 mfin Tier One Leverage Capital Required For Capital Adequacy To Total Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToTotalAssets
0.15
CY2022Q1 mfin Tier One Leverage Capital Ratio
TierOneLeverageCapitalRatio
0.1751
CY2022Q1 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
205731000
CY2021Q4 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
193459000
CY2022Q1 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
274519000
CY2021Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
262247000
CY2022Q1 us-gaap Capital
Capital
294472000
CY2021Q4 us-gaap Capital
Capital
281211000
CY2022Q1 mfin Average Assets
AverageAssets
1567781000
CY2021 mfin Average Assets
AverageAssets
1495726000
CY2022Q1 us-gaap Risk Weighted Assets
RiskWeightedAssets
1563232000
CY2021Q4 us-gaap Risk Weighted Assets
RiskWeightedAssets
1482678000
CY2022Q1 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
4.0
CY2022Q1 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
5.0
CY2022Q1 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
17.5
CY2022Q1 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
17.6
CY2021Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
17.7
CY2022Q1 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
10.5
CY2022Q1 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
10.0
CY2022Q1 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
18.8
CY2021Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
19.0
CY2022Q1 mfin Tier One Capital Conversation Buffer
TierOneCapitalConversationBuffer
0.025
CY2021Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
17.5
CY2022Q1 mfin Common Equity Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.070
CY2022Q1 mfin Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.065
CY2022Q1 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
13.2
CY2021Q4 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
13.1
CY2022Q1 us-gaap Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
8.5
CY2022Q1 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
8.0
CY2021 mfin Tier One Capital Conversation Buffer
TierOneCapitalConversationBuffer
0.025
CY2022Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications have been made to prior year balances to conform with the current year presentation. These reclassifications have no effect on the previously reported results of operations.</span></p>
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
49182000
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
122000
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2229000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
47075000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
44494000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
732000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
454000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
44772000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
22000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
22000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
9568000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
9494000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
9734000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
9238000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
29858000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
28321000
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
49182000
CY2021Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
58660000
CY2021Q1 mfin Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod
184000
CY2022Q1 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
32891000
CY2021Q4 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
35571000
CY2022Q1 mfin Interest Income Foregone On Non Accrual Loans
InterestIncomeForegoneOnNonAccrualLoans
754000
CY2021 mfin Interest Income Foregone On Non Accrual Loans
InterestIncomeForegoneOnNonAccrualLoans
1620000
CY2022Q1 mfin Amount Of Foregone Interest Applied To Principal
AmountOfForegoneInterestAppliedToPrincipal
107000
CY2021 mfin Amount Of Foregone Interest Applied To Principal
AmountOfForegoneInterestAppliedToPrincipal
432000
CY2022Q1 mfin Interest Foregone Life To Date
InterestForegoneLifeToDate
2458000
CY2021 mfin Interest Foregone Life To Date
InterestForegoneLifeToDate
3623000
CY2022Q1 mfin Amount Of Foregone Interest Applied To Principal Life To Date
AmountOfForegoneInterestAppliedToPrincipalLifeToDate
1016000
CY2021 mfin Amount Of Foregone Interest Applied To Principal Life To Date
AmountOfForegoneInterestAppliedToPrincipalLifeToDate
942000
CY2022Q1 us-gaap Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
0.02
CY2021Q4 us-gaap Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
0.02
CY2022Q1 mfin Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans
LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans
1.54
CY2021Q4 mfin Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans
LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans
1.41
CY2022Q1 us-gaap Loans And Leases Receivable Loans In Process
LoansAndLeasesReceivableLoansInProcess
1569441000
CY2022Q1 mfin Loans And Leases Receivable Non Performing Percentage
LoansAndLeasesReceivableNonPerformingPercentage
0.0211
CY2021Q4 us-gaap Loans And Leases Receivable Loans In Process
LoansAndLeasesReceivableLoansInProcess
1488924000
CY2021 mfin Loans And Leases Receivable Non Performing Percentage
LoansAndLeasesReceivableNonPerformingPercentage
0.0242
CY2022Q1 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
33154000
CY2022Q1 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
34171000
CY2022Q1 mfin Impaired Financing Receivables With Related Allowance Related Allowance
ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance
10260000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
36065000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
37007000
CY2021Q4 mfin Impaired Financing Receivables With Related Allowance Related Allowance
ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance
10168000
CY2022Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
37816000
CY2022Q1 mfin Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod
130000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
47075000
CY2022Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
896000
CY2022Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
21981000
CY2022Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1333000
CY2022Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
12514000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
412000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
18454000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
42000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
1956000
CY2022Q1 mfin Number Of Securities
NumberOfSecurities
37
CY2021Q4 mfin Number Of Securities
NumberOfSecurities
15
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
50166000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
57548000
CY2022Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-7786000
CY2021Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-6848000
CY2022Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
5066000
CY2021Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
4090000
CY2022Q1 us-gaap Allowance For Loan And Lease Losses Writeoffs Net
AllowanceForLoanAndLeaseLossesWriteoffsNet
-2720000
CY2021Q1 us-gaap Allowance For Loan And Lease Losses Writeoffs Net
AllowanceForLoanAndLeaseLossesWriteoffsNet
-2758000
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3240000
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3019000
CY2022Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
50686000
CY2021Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
57809000
CY2022Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
50686000
CY2022Q1 mfin Percentage Of Allowance For Loan Losses
PercentageOfAllowanceForLoanLosses
1
CY2022Q1 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans
0.0323
CY2022Q1 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual
1.5410
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
50166000
CY2021Q4 mfin Percentage Of Allowance For Loan Losses
PercentageOfAllowanceForLoanLosses
1
CY2021Q4 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans
0.0337
CY2021Q4 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual
1.4103
CY2022Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
31393000
CY2022Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1540642000
CY2022Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2022Q1 us-gaap Federal Home Loan Bank Advances Premium
FederalHomeLoanBankAdvancesPremium
400000
CY2022Q1 mfin Capitalized Loan Origination Costs
CapitalizedLoanOriginationCosts
28400000
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
41761000
CY2021Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1461622000
CY2021Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2021Q4 us-gaap Federal Home Loan Bank Advances Premium
FederalHomeLoanBankAdvancesPremium
500000
CY2021 mfin Capitalized Loan Origination Costs
CapitalizedLoanOriginationCosts
26800000
CY2021Q4 mfin Loan To Value Ratio
LoanToValueRatio
2.95
CY2021Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
37430000
CY2022Q1 mfin Loan In Process Of Foreclosure Loans Transfer
LoanInProcessOfForeclosureLoansTransfer
3040000
CY2022Q1 mfin Loan In Process Of Foreclosure Loan Sales
LoanInProcessOfForeclosureLoanSales
-2368000
CY2022Q1 mfin Loan In Process Of Foreclosure Loans Cash Payment Received
LoanInProcessOfForeclosureLoansCashPaymentReceived
-2872000
CY2022Q1 mfin Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments
LoanInProcessOfForeclosureLoansCollateralValuationAdjustments
-1396000
CY2022Q1 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
33834000
CY2020Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
54560000
CY2021Q1 mfin Loan In Process Of Foreclosure Loans Transfer
LoanInProcessOfForeclosureLoansTransfer
3802000
CY2021Q1 mfin Loan In Process Of Foreclosure Loan Sales
LoanInProcessOfForeclosureLoanSales
-2298000
CY2021Q1 mfin Loan In Process Of Foreclosure Loans Cash Payment Received
LoanInProcessOfForeclosureLoansCashPaymentReceived
-1329000
CY2021Q1 mfin Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments
LoanInProcessOfForeclosureLoansCollateralValuationAdjustments
-4002000
CY2021Q1 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
50733000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
410783000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
292840000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
364713000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
217715000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
164752000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
107750000
CY2022Q1 mfin Debt Long Term And Short Term Funds Borrowed Amount
DebtLongTermAndShortTermFundsBorrowedAmount
1558553000
CY2021Q4 mfin Debt Long Term And Short Term Funds Borrowed Amount
DebtLongTermAndShortTermFundsBorrowedAmount
1477251000
CY2022Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0184
CY2022Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
7200000
CY2021Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
7100000
CY2022Q1 mfin Reserve Deposits
ReserveDeposits
800000
CY2021Q4 mfin Reserve Deposits
ReserveDeposits
800000
CY2022Q1 mfin Number Of Individual With Time Deposits Greater Than100000
NumberOfIndividualWithTimeDepositsGreaterThan100000
0
CY2022Q1 mfin Listing Services Deposits From Other Financial Institutions
ListingServicesDepositsFromOtherFinancialInstitutions
8700000
CY2021Q4 mfin Listing Services Deposits From Other Financial Institutions
ListingServicesDepositsFromOtherFinancialInstitutions
8700000
CY2022Q1 us-gaap Contractual Maturities Time Deposits100000 Or More Three Months Or Less
ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsOrLess
168243000
CY2022Q1 us-gaap Contractual Maturities Time Deposits100000 Or More Three Months Through Six Months
ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsThroughSixMonths
73985000
CY2022Q1 us-gaap Contractual Maturities Time Deposits100000 Or More Six Months Through12 Months
ContractualMaturitiesTimeDeposits100000OrMoreSixMonthsThrough12Months
163555000
CY2022Q1 us-gaap Contractual Maturities Time Deposits100000 Or More After12 Months
ContractualMaturitiesTimeDeposits100000OrMoreAfter12Months
929006000
CY2022Q1 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
1334789000
CY2022Q1 mfin Debt Instrument Maturity Year
DebtInstrumentMaturityYear
2021
CY2020Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
25000000.0
CY2020Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-09-24
CY2022Q1 mfin Remaining Amount Of Debenture After Deducting Leverage Fee
RemainingAmountOfDebentureAfterDeductingLeverageFee
4800000
CY2007Q4 us-gaap Payments For Repurchase Of Trust Preferred Securities
PaymentsForRepurchaseOfTrustPreferredSecurities
2000000.0
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
590000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
572000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
645000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
675000
CY2022Q1 mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-45000
CY2021Q1 mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-18000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9536000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10045000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2153000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2159000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8548000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9053000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
10701000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
11212000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y4M24D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0097
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5398
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
951669
CY2020Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2020Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
12.55
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.41
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
317398
CY2021 mfin Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice
6.79
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.79
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
113310
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.64
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
44070
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.58
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1111687
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0554
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0554
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1823000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2356000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2373000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2390000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2408000
CY2022Q1 mfin Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1164000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12514000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1813000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
10701000
CY2022Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
43766000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
43894000
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
10115000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
11057000
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9627000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
12167000
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
1901000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
2579000
CY2022Q1 mfin Deferred Tax Liabilities Unrealized Loss On Other Investments
DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments
-2687000
CY2021Q4 mfin Deferred Tax Liabilities Unrealized Loss On Other Investments
DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments
-2176000
CY2022Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
19436000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
15915000
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2295000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2295000
CY2022Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
21731000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
18210000
CY2022Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
1800000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
504000
CY2021Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2022Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
322000
CY2021Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
170000
CY2022Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3220000
CY2021Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3053000
CY2022Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
785000
CY2021Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
655000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4831000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3878000
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
3399000
CY2021Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2719000
CY2022Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
665000
CY2021Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
532000
CY2022Q1 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
0
CY2021Q1 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
170000
CY2022Q1 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
0
CY2021Q1 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-200000
CY2022Q1 us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
0
CY2021Q1 us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
219000
CY2022Q1 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
713000
CY2021Q1 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
172000
CY2022Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
54000
CY2021Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
704000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4831000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3878000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1083712
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
554119
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
12.55
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.41
CY2022Q1 mfin Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
554119
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
4783
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
5.69
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
23192
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.53
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1083712
CY2022Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2022Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
12.55
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.53
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
320922
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit
2.14
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit
12.55
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.53
CY2022Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit
2.14
CY2022Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit
12.55
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.54
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2200000
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1100000
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y3M18D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
790765
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit
4.89
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit
7.25
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.52
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
4200
CY2022Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareLowerRangeLimit
4.89
CY2022Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareUpperRangeLimit
7.25
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
5.48
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
256972
CY2022Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeLowerRangeLimit
4.89
CY2022Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeUpperRangeLimit
7.25
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
6.55
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
529593
CY2022Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit
4.89
CY2022Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit
7.25
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.52
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
100000
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
6
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
CY2022Q1 mfin Number Of Non Operating Segments
NumberOfNonOperatingSegments
2
CY2022Q1 mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
43303000
CY2022Q1 mfin Interest Expense Net
InterestExpenseNet
7375000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
35928000
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3240000
CY2022Q1 mfin Net Interest Margin
NetInterestMargin
0.0920
CY2022Q1 mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0323
CY2022Q1 mfin Delinquency Status
DelinquencyStatus
0.0027
CY2022Q1 mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
0.0075
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
32688000
CY2022Q1 mfin Non Interest Expense Income
NonInterestExpenseIncome
16504000
CY2022Q1 mfin Net Income Loss Before Taxes
NetIncomeLossBeforeTaxes
16184000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4831000
CY2022Q1 mfin Net Income Loss After Taxes
NetIncomeLossAfterTaxes
11353000
CY2022Q1 mfin Total Loans Net
TotalLoansNet
1518755000
CY2022Q1 us-gaap Assets
Assets
1966625000
CY2022Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1559304000
CY2022Q1 mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
0.0241
CY2022Q1 mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
0.1370
CY2022Q1 mfin Interest Yield
InterestYield
0.1106
CY2021Q1 mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
37080000
CY2021Q1 mfin Interest Expense Net
InterestExpenseNet
8407000
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
28673000
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3019000
CY2021Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
25654000
CY2021Q1 mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
2473000
CY2021Q1 mfin Race Team Related Expense
RaceTeamRelatedExpense
-2122000
CY2021Q1 mfin Non Interest Expense Income
NonInterestExpenseIncome
-13056000
CY2021Q1 mfin Net Income Loss Before Taxes
NetIncomeLossBeforeTaxes
12949000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3878000
CY2021Q1 mfin Net Income Loss After Taxes
NetIncomeLossAfterTaxes
9071000
CY2021Q1 mfin Total Loans Net
TotalLoansNet
1201406000
CY2021Q1 us-gaap Assets
Assets
1688750000
CY2021Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1346759000
CY2021Q1 mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
0.0208
CY2021Q1 mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
0.1109
CY2021Q1 mfin Interest Yield
InterestYield
0.1184
CY2021Q1 mfin Net Interest Margin
NetInterestMargin
0.0918
CY2021Q1 mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0459
CY2021Q1 mfin Delinquency Status
DelinquencyStatus
0.0033
CY2021Q1 mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
0.0095
CY2022Q1 mfin Employment Agreement Description
EmploymentAgreementDescription
Employment agreements expire at various dates through 2026
CY2022Q1 mfin Employment Agreements Future Minimum Payments Due
EmploymentAgreementsFutureMinimumPaymentsDue
12000000.0
CY2022Q1 us-gaap Other Commitment
OtherCommitment
1800000
CY2022Q1 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
-1700000
CY2021 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
-1000000.0
CY2021Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
37430000

Files In Submission

Name View Source Status
0000950170-22-007799-index-headers.html Edgar Link pending
0000950170-22-007799-index.html Edgar Link pending
0000950170-22-007799.txt Edgar Link pending
0000950170-22-007799-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mfin-20220331.htm Edgar Link pending
mfin-20220331.xsd Edgar Link pending
mfin-20220331_cal.xml Edgar Link unprocessable
mfin-20220331_def.xml Edgar Link unprocessable
mfin-20220331_htm.xml Edgar Link completed
mfin-20220331_lab.xml Edgar Link unprocessable
mfin-20220331_pre.xml Edgar Link unprocessable
mfin-ex31_1.htm Edgar Link pending
mfin-ex31_2.htm Edgar Link pending
mfin-ex32_1.htm Edgar Link pending
mfin-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending